Furthermore, we evaluated the role of hypoxia-inducible factor-1 alpha (HIF-1α) in obesity-AD comorbidity, and then investigated whether it is regulated by TJT treatment. The gene discussed is HIF1A; the disease is obesity due to melanocortin 4 receptor deficiency.